Penumbra, Inc.
PEN NYSEHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Jul 30, 2026
ET
EPS Est.
1.16
EPS Actual
0.88
Revenue Est.
$389.6M
Revenue Actual
$390M
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
1.20
Revenue Est.
$401.4M
Company Overview
Penumbra, Inc. (ticker PEN) is listed on NYSE with a market cap of about $12.81B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), After-market, with consensus EPS of 1.20. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Jul 30, 2026
Feb 23, 2023Range: 0.16 ~ 1.18Jul 30, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 30, 2026 | -- | 1.16 | Below forecast↓0.88 | $389.6M | $390M |
| May 6, 2026 | -- | 1.04 | Below forecast↓0.82 | $370.5M | $374.8M |
| Feb 25, 2026 | -- | 1.11 | 1.18 | $361.9M | $385.4M |
| Nov 5, 2025 | -- | 0.93 | 0.97 | $341M | $354.7M |
| Jul 29, 2025 | -- | 0.81 | 0.86 | $341.3M | $339.5M |
| Apr 23, 2025 | -- | 0.66 | Above forecast↑0.83 | $327.3M | $324.1M |
| Feb 18, 2025 | -- | 0.88 | 0.97 | $311.6M | $315.5M |
| Oct 30, 2024 | -- | 0.69 | Above forecast↑0.85 | $311.6M | $301M |
| Jul 30, 2024 | -- | 0.56 | 0.64 | $298.4M | $299.4M |
| May 7, 2024 | -- | 0.42 | 0.41 | $274.9M | $278.7M |
| Feb 22, 2024 | -- | 0.71 | 0.76 | $286.6M | $284.7M |
| Nov 2, 2023 | -- | 0.46 | Above forecast↑0.67 | $265.3M | $270.9M |
| Aug 1, 2023 | -- | 0.28 | Above forecast↑0.43 | $253.2M | $261.5M |
| May 2, 2023 | -- | 0.11 | Above forecast↑0.23 | $229.7M | $241.4M |
| Feb 23, 2023 | -- | 0.14 | 0.16 | $217.3M | $221.2M |
Original Filings (SEC)
10-Q2026-07-30 ↗
8-K2026-07-30 ↗
8-K2026-06-22 ↗
8-K2026-05-07 ↗
10-Q2026-05-06 ↗
8-K2026-05-06 ↗
10-K2026-02-25 ↗
8-K2026-02-25 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
